Literature DB >> 7711213

Ontogeny of reproductive abnormalities induced by deregulation of anti-müllerian hormone expression in transgenic mice.

L Lyet1, F Louis, M G Forest, N Josso, R R Behringer, B Vigier.   

Abstract

Anti-müllerian hormone, normally responsible for the regression of müllerian ducts in male fetuses, induces stunting, germ cell loss, and seminiferous tubule formation in ovaries of bovine freemartin fetuses and of transgenic mice, which express the human anti müllerian hormone gene under the control of the metallothionein promoter. Because the latter have been studied only after birth, we undertook a detailed chronological study of their reproductive organs. Müllerian ducts of transgenic female fetuses regressed at the same time as those of normal or transgenic males. Maximal reduction of germ cell number occurred between 16 days postcoitus and birth, when most transgenic oocytes were still in the leptotene stage of the meiotic prophase, whereas normal oocytes had already reached the pachytene phase. Interference with progression of the meiotic prophase and germ cell loss in the fetal ovary are probably responsible for subsequent ovarian regression and retardation of follicle growth. Seminiferous tubule formation was not detectable prior to birth and occurred only rarely in postnatal ovaries. Aromatase activity of fetal transgenic ovaries was decreased, as well as serum concentration of testosterone in adult transgenic males, suggesting that high levels of anti-müllerian hormone may impair Leydig cell steroidogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7711213     DOI: 10.1095/biolreprod52.2.444

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  15 in total

Review 1.  Stem Leydig cells: from fetal to aged animals.

Authors:  Haolin Chen; Erin Stanley; Shiying Jin; Barry R Zirkin
Journal:  Birth Defects Res C Embryo Today       Date:  2010-12

2.  Combined loss of the GATA4 and GATA6 transcription factors in male mice disrupts testicular development and confers adrenal-like function in the testes.

Authors:  Maria B Padua; Tianyu Jiang; Deborah A Morse; Shawna C Fox; Heather M Hatch; Sergei G Tevosian
Journal:  Endocrinology       Date:  2015-02-10       Impact factor: 4.736

Review 3.  Determination and stability of gonadal sex.

Authors:  David Schlessinger; José-Elias Garcia-Ortiz; Antonino Forabosco; Manuela Uda; Laura Crisponi; Emanuele Pelosi
Journal:  J Androl       Date:  2009-10-29

4.  Effect of Anti-Müllerian hormone (AMH) and bone morphogenetic protein 15 (BMP-15) on steroidogenesis in primary-cultured human luteinizing granulosa cells through Smad5 signalling.

Authors:  Ermioni Prapa; Anna Vasilaki; Konstantinos Dafopoulos; Eleni Katsiani; Panagiotis Georgoulias; Christina I Messini; George Anifandis; Ioannis E Messinis
Journal:  J Assist Reprod Genet       Date:  2015-05-24       Impact factor: 3.412

5.  Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.

Authors:  Xiufeng Wu; Ningning Zhang; Mary M Lee
Journal:  Endocrinology       Date:  2012-08-07       Impact factor: 4.736

6.  Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents.

Authors:  A M Trbovich; P M Sluss; V M Laurich; F H O'Neill; D T MacLaughlin; P K Donahoe; J Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

7.  Transcriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cells.

Authors:  J Teixeira; D J Kehas; R Antun; P K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

8.  Receptors for anti-müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation.

Authors:  C Racine; R Rey; M G Forest; F Louis; A Ferré; I Huhtaniemi; N Josso; N di Clemente
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

9.  Regulation of gonadotropin gene expression by Mullerian inhibiting substance.

Authors:  Grégoy Y Bédécarrats; Francis H O'Neill; Errol R Norwitz; Ursula B Kaiser; Jose Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

10.  Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population.

Authors:  Monica Mortensen; David A Ehrmann; Elizabeth Littlejohn; Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.